Abstract
Semiconducting single-walled carbon nanotubes (SWCNTs) are emerging as powerful near-infrared probes for deep-tissue imaging. While SWCNT samples involving multiple chiralities can be seen as a collection of spectrally-resolved fluorophores, their multiplex imaging capabilities remain underexplored. Here we present chirality-resolved evaluation of DSPE-mPEG coated CoMoCAT SWCNTs integrating optical characterization, biodistribution, pharmacokinetics, and toxicity studies in BALB/c mice. Narrow band-pass filters centered at 1000, 1050, and 1100 nm are used to isolate emission from the dominant (6,5) species and coexisting (7,5) and (7,6) chiralities within the NIR-II window. Following intraperitoneal administration, longitudinal whole-body imaging (0.5-24 h) illustrate rapid systemic spread and preferential uptake in reticuloendothelial organs. Ex vivo organ analysis reveals a hierarchy of emission intensities (liver ≫ spleen ≈ kidney ≫ lung ≈ heart) that is preserved across all three detection channels suggesting a negligible influence of SWCNT chirality on biodistribution. Serum kinetics show monoexponential decay with an apparent elimination half-life ~ 0.93 h and no significant sex-dependent differences. In a 21-day toxicity study, treated animals maintain stable body mass and normal behavior, organ-level fluorescence returns to baseline, and H&E sections of liver, kidney and lung reveal preserved architecture without inflammatory or fibrotic lesions. Collectively, this work defines safe dosing and imaging conditions for DSPE-mPEG/CoMoCAT SWCNTs and demonstrates that chirality-specific NIR-II fluorescence can be exploited for multiplex tracking of nanotube probes in vivo, providing a foundation for future biosensing and image-guided therapeutic applications.